|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.409 EUR | +1.31% |
|
+1.97% | +17.61% |
| 13/01 | Evotec says Michael Kaufman holds 5.03% of total voting rights and instruments in Evotec | RE |
| 08/01 | Evotec Receives Gates Foundation Grant to Deploy AI in Optimizing Monoclonal Antibodies | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 6.552 | 7.456 | 7.054 |
| Spread/Res. | -2.17% | -14.03% | -9.13% |
| Spread/Supp. | +10.25% | +25.59% | +23.98% |
| Support | 5.814 | 5.104 | 5.17 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- EVT Stock
- Charts Evotec SE
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition